GVB Biopharma Sees Cannabidiolic Acid (CBDa) in Sizable Increase when Converted by Superheating or Exposure to UV Light

GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related consumer products, is experiencing a sizable increase in interest and orders for cannabidiolic acid, a cannabinoid popularly known as CBDa.Since the first month that CBDa sales began at GVB, internal data shows that the company has seen a 5,000% increase in CBDa orders. Revenue from…